Cargando…

Pubertal development in HIV-infected African children on first-line antiretroviral therapy

OBJECTIVES: To estimate age at attaining Tanner stages in Ugandan/Zimbabwean HIV-infected children initiating antiretroviral therapy (ART) in older childhood and investigate predictors of delayed puberty, particularly age at ART initiation. DESIGN: Observational analysis within a randomized trial. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szubert, Alexander J., Musiime, Victor, Bwakura-Dangarembizi, Mutsawashe, Nahirya-Ntege, Patricia, Kekitiinwa, Adeodata, Gibb, Diana M., Nathoo, Kusum, Prendergast, Andrew J., Walker, A. Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Epidemiology and Social
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342414/ https://www.ncbi.nlm.nih.gov/pubmed/25710288 http://dx.doi.org/10.1097/QAD.0000000000000590

Ejemplares similares

Prevalence of Lipodystrophy and Metabolic Abnormalities in HIV-infected African Children after 3 Years on First-line Antiretroviral Therapy
por: Bwakura-Dangarembizi, Mutsawashe, et al.
Publicado: (2015)

Opportunities for improving the efficiency of paediatric HIV treatment programmes
por: Revill, Paul A., et al.
Publicado: (2015)

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy
por: Crook, Angela M., et al.
Publicado: (2016)

Predicting Patterns of Long-Term CD4 Reconstitution in HIV-Infected Children Starting Antiretroviral Therapy in Sub-Saharan Africa: A Cohort-Based Modelling Study
por: Picat, Marie-Quitterie, et al.
Publicado: (2013)

Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis
por: Prendergast, Andrew J., et al.
Publicado: (2016)

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial
por: Szubert, Alexander J., et al.
Publicado: (2017)

Mortality in the Year Following Antiretroviral Therapy Initiation in HIV-Infected Adults and Children in Uganda and Zimbabwe
por: Walker, A. Sarah, et al.
Publicado: (2012)

Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy
por: Prendergast, Andrew J., et al.
Publicado: (2016)

Brief Report: Cessation of Long-Term Cotrimoxazole Prophylaxis in HIV-Infected Children Does Not Alter the Carriage of Antimicrobial Resistance Genes
por: Francis, Freddy, et al.
Publicado: (2020)

Marginal structural models for repeated measures where intercept and slope are correlated: An application exploring the benefit of nutritional supplements on weight gain in HIV-infected children initiating antiretroviral therapy
por: Farmer, Ruth E., et al.
Publicado: (2020)

The relationship between leadership style and health worker motivation, job satisfaction and teamwork in Uganda
por: Musinguzi, Conrad, et al.
Publicado: (2018)

Early mortality following ART initiation in HIV-infected adults and children in Uganda and Zimbabwe
por: Walker, AS, et al.
Publicado: (2010)

Pharmacokinetics of lamivudine, abacavir and zidovudine administered twice daily as syrups versus scored tablets in HIV-1-infected Ugandan children
por: Gitta, PK, et al.
Publicado: (2010)

Prevalence and correlates of HIV testing among adolescents 10–19 years in a post-conflict pastoralist community of Karamoja region, Uganda
por: Ssebunya, Rogers N., et al.
Publicado: (2018)

Ethical and legal constraints to children’s participation in research in Zimbabwe: experiences from the multicenter pediatric HIV ARROW trial
por: Bwakura-Dangarembizi, Mutsa, et al.
Publicado: (2012)

Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age
por: Ciaranello, Andrea L., et al.
Publicado: (2015)

Global variations in pubertal growth spurts in adolescents living with perinatal HIV
Publicado: (2023)

Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 Trial
por: Bevers, Lisanne A H, et al.
Publicado: (2023)

Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial
por: Kityo, Cissy, et al.
Publicado: (2018)

Evaluation of weight‐based prescription of antiretroviral therapy in children
por: Dakshina, S, et al.
Publicado: (2019)

Young HIV-Infected Children and Their Adult Caregivers Prefer Tablets to Syrup Antiretroviral Medications in Africa
por: Nahirya-Ntege, Patricia, et al.
Publicado: (2012)

Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial
por: Siika, Abraham, et al.
Publicado: (2018)

Sexual behaviour in a rural high HIV prevalence South African community: time trends in the antiretroviral treatment era
por: McGrath, Nuala, et al.
Publicado: (2013)

Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial
por: Mallewa, Jane, et al.
Publicado: (2018)

Risk factors for postdischarge mortality following hospitalization for severe acute malnutrition in Zimbabwe and Zambia
por: Bwakura-Dangarembizi, Mutsa, et al.
Publicado: (2021)

The cost‐effectiveness of prophylaxis strategies for individuals with advanced HIV starting treatment in Africa
por: Walker, Simon M, et al.
Publicado: (2020)

First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial
por: Waalewijn, Hylke, et al.
Publicado: (2023)

Adherence to oral antiretroviral therapy in Canada, 2010–2020
por: Angel, Jonathan B., et al.
Publicado: (2023)

The Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal Structural Models
por: Ford, Deborah, et al.
Publicado: (2015)

Predicting virological decay in patients starting combination antiretroviral therapy
Publicado: (2016)

HIV-associated wasting prevalence in the era of modern antiretroviral therapy
por: Siddiqui, Javeed, et al.
Publicado: (2022)

Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure
por: Shroufi, Amir, et al.
Publicado: (2019)

Patient-reported barriers and facilitators to antiretroviral adherence in sub-Saharan Africa
por: Croome, Natasha, et al.
Publicado: (2017)

Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial
por: Post, Frank A, et al.
Publicado: (2018)

Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis
por: Kim, Sung-Hee, et al.
Publicado: (2014)

Milk Calcium and Phosphorus in Ugandan Women with HIV on Tenofovir-Based Antiretroviral Therapy
por: Nabwire, Florence, et al.
Publicado: (2023)

Impact of short message service and peer navigation on linkage to care and antiretroviral therapy initiation in South Africa
por: Lippman, Sheri A., et al.
Publicado: (2023)

Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study
por: Piloya, Thereza, et al.
Publicado: (2012)

Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial
por: Mulenga, Veronica, et al.
Publicado: (2016)

Effect of antiretroviral therapy on patients’ economic well being: five-year follow-up
por: Rosen, Sydney, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_67q2f3v90i9ckj2doi9al9n3ha